Provided by Tiger Fintech (Singapore) Pte. Ltd.

TNF Pharmaceuticals, Inc.

5.20
0.0000
Volume:- -
Turnover:- -
Market Cap:9.29M
PE:-0.01
High:5.20
Open:5.20
Low:5.20
Close:5.20
52wk High:195.00
52wk Low:3.24
Shares:1.79M
Float Shares:1.79M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-558.7158
EPS(LYR):-1,114.5350
ROE:-115.40%
ROA:-24.00%
PB:1.81
PE(LYR):0.00

Loading ...

TNF Pharmaceuticals Changes Name to Q/C Technologies, Unveils New Ticker "QCLS

Reuters
·
Sep 24

Tnf Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “Qcls” to Reflect Strategic Focus on Quantum Class Photonic Computing

THOMSON REUTERS
·
Sep 24

TNF Pharmaceuticals Regains Compliance With Nasdaq Listing Requirement

MT Newswires Live
·
Sep 17

TNF Pharmaceuticals regains compliance with Nasdaq

TIPRANKS
·
Sep 17

TNF Pharmaceuticals Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York City

Reuters
·
Sep 08

TNF Pharmaceuticals Inc. Issues Correction to September Report on Membership Interest Purchase Agreement

Reuters
·
Sep 06

TNF Pharmaceuticals Secures $7 Million in Private Placement to Advance Innovative Technology

Reuters
·
Sep 04

Tnf Pharmaceuticals Announces Closing of $7 Million Private Placement

THOMSON REUTERS
·
Sep 04

Tnf Pharmaceuticals Inc Enters Into Licensing Agreement With Lightsolver For Innovative Compute Accelerator Tech

Reuters
·
Sep 03

TNF Pharmaceuticals Inc. Expands into Cryptocurrency with Exclusive Global Rights to Light-Based Computing Technology

Reuters
·
Sep 02

PharmaCyte Biotech Inc - Increases Stake in Tnf Pharmaceuticals by $3 Mln

THOMSON REUTERS
·
Sep 02

Tnf Pharmaceuticals Inc - Enters $7 Mln Private Placement Financing Agreement

THOMSON REUTERS
·
Sep 02

Tnf Pharmaceuticals Inc: Intends to Change Its Name in Accordance With Its New Venture

THOMSON REUTERS
·
Sep 02

TNF Pharmaceuticals Announces Name Change to Reflect New Cryptocurrency Focus

Reuters
·
Sep 02

TNF Pharmaceuticals Announces 1-for-100 Reverse Stock Split for Nasdaq Compliance

Reuters
·
Aug 28

Tnf Pharmaceuticals Inc - Announces 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
Aug 28

TNF Pharmaceuticals Q2 EPS $(0.18) Up From $(4.54) YoY

Benzinga
·
Aug 20

TNF Pharmaceuticals Delays Q2 2025 Financial Report Due to Finalization Needs

Reuters
·
Aug 15

TNF Pharmaceuticals Partners with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Disease

Reuters
·
Jun 24

TNF Pharmaceuticals Inc. Held Annual Stockholders Meeting

Reuters
·
Jun 07